Skip to main content
. 2011 May 6;54(8):1985–1991. doi: 10.1007/s00125-011-2167-8

Table 1.

Demographics and baseline characteristics

Variable Vildagliptin 100 mg once daily Placebo
n 29 30
Age (years) 57.4 ± 9.4 57.0 ± 6.7
Men 17 (58.6) 18 (60.0)
Europid 28 (96.6) 27 (90.0)
Body weight (kg) 90.2 ± 15.9 87.6 ± 19.1
BMI (kg/m2) 29.9 ± 4.9 29.2 ± 4.4
Waist circumference (cm) 100.7 ± 10.9 99.5 ± 12.8
HbA1c (%) 6.0 ± 0.7 6.0 ± 0.7
FPG (mmol/l) 7.0 ± 1.2 7.1 ± 1.0
Disease duration (y) 1.4 ± 2.8 0.6 ± 1.1

Data are presented as mean ± SD or n (%)